Back to results
US 2025/0018026 A1Published application
Nasal vaccine-spraying formulation for simultaneously targeting nasal mucosa and nasopharynx
AssigneeToko Yakuhin Kogyo Kabushiki Kaisha
InventorsTaizou KAMISHITA, Takashi MIYAZAKI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a formulation base prepared by adding polyethylene glycol to crosslinked polyacrylic acid, and a formulation for spraying nasal vaccine comprising an antigen, which have optimized spray pattern targeting simultaneously both of nasal mucosa and nasopharynx.
Claims13
A formulation for spraying nasal vaccine, comprising an antigen and a formulation base prepared by adding polyethylene glycol to crosslinked polyacrylic acid.
A formulation base used in a formulation for spraying nasal vaccine, which is prepared by adding polyethylene glycol to crosslinked polyacrylic acid.
Dependencies are inferred from the claim text.